Advantages of the single delay model for the assessment of insulin sensitivity from the intravenous glucose tolerance test

Theoretical Biology & Medical Modelling
Simona PanunziGeltrude Mingrone

Abstract

The Minimal Model, (MM), used to assess insulin sensitivity (IS) from Intra-Venous Glucose-Tolerance Test (IVGTT) data, suffers from frequent lack of identifiability (parameter estimates with Coefficients of Variation (CV) less than 52%). The recently proposed Single Delay Model (SDM) is evaluated as a practical alternative. The SDM was applied to 74 IVGTTs from lean (19), overweight (22), obese (22) and morbidly obese (11) subjects. Estimates from the SDM (K xgI) were compared with the corresponding MM (S I), 1/HOMA-IR index and Euglycemic-Hyperinsulinemic Clamp (M-EHC over 7 subjects) estimates. K xgI was identifiable in 73 out of 74 subjects (CV = 69% in the 74 th subject) and ranged from 1.25 x 10(-5) to 4.36 x 10(-4) min(-1) pM(-1); S I CV was >52% in 36 subjects (up to 2.36 x 10(9)%) and presented 18 extreme values (<or= 1.5 x 10(-12) or >or= 3.99). K xgI correlated well with 1/HOMA-IR (r = 0.56, P < 0.001), whereas the correlations K xgI-S I and 1/HOMA-IR-S I were high (r = 0.864 and 0.52 respectively) and significant (P < 0.001 in both cases) only in the non-extreme SI sub-sample (56 subjects). Correlations K xgI vs. M-EHC and SI vs. M-EHC were positive (r = 0.92, P = 0.004 and r = 0.83, P = 0.02 respectively). K xgI de...Continue Reading

References

Jun 1, 1991·Diabetes Care·A M Fontbonne, E M Eschwège
Aug 6, 1987·The New England Journal of Medicine·E FerranniniS Bevilacqua
Jun 1, 1988·The American Journal of Physiology·E Van Cauter
Apr 11, 1996·The New England Journal of Medicine·J P DesprésP J Lupien
Sep 26, 1997·The Journal of Clinical Investigation·E FerranniniG Mingrone
Apr 13, 1999·The Journal of Clinical Endocrinology and Metabolism·R J Mahler, M L Adler
Apr 1, 2000·Journal of Mathematical Biology·A De Gaetano, O Arino
Feb 28, 2001·Diabetes, Obesity & Metabolism·L C Groop
Mar 20, 2003·Current Diabetes Reports·James B Meigs
Jun 11, 2003·Journal of Clinical Pharmacy and Therapeutics·P PeterM J Kendall
Nov 25, 2004·Diabetes·Ele FerranniniAndrea Mari
Feb 1, 2006·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Geoffrey C Farrell, Claire Z Larter
Mar 15, 2006·IEEE Transactions on Bio-medical Engineering·Gianluigi PillonettoClaudio Cobelli
Sep 14, 2007·Theoretical Biology & Medical Modelling·Simona PanunziAndrea De Gaetano

❮ Previous
Next ❯

Citations

Aug 28, 2013·Theoretical Biology & Medical Modelling·Robert G HahnStefan Ljunggren
Nov 30, 2011·Mathematical Biosciences·Jiaxu LiSimona Panunzi
Sep 29, 2011·Mathematical Biosciences·Jerry J Batzel, Franz Kappel
Sep 17, 2014·Mathematical Biosciences·P PalumboA De Gaetano
Sep 2, 2016·Mathematical Biosciences·Liam FiskJ Geoffrey Chase
Mar 3, 2011·American Journal of Physiology. Endocrinology and Metabolism·Serenella SalinariGeltrude Mingrone
Jul 25, 2019·Theory in Biosciences = Theorie in Den Biowissenschaften·Fateme Mohabati, MohammadReza Molaei
May 3, 2012·American Journal of Physiology. Endocrinology and Metabolism·Thomas HardyAndrea De Gaetano

❮ Previous
Next ❯

Software Mentioned

HOMA Calculator
Matlab
R

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

Related Papers

Theoretical Biology & Medical Modelling
Simona PanunziAndrea De Gaetano
Journal of Mathematical Biology
Andrea De Gaetano, O Arino
American Journal of Physiology. Endocrinology and Metabolism
Chiara Dalla ManClaudio Cobelli
American Journal of Physiology. Endocrinology and Metabolism
Chiara Dalla ManClaudio Cobelli
© 2022 Meta ULC. All rights reserved